Transcode Therapeutics Inc (RNAZ) Annual Balance Sheets

Annual · GAAP · USD millions
Access RNAZ quarterly Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Transcode Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent17.81
Security Deposit0.00
Cash & Short-term Investments17.00
Other Receivables, Net, Current0.00
Grants Receivable, Current0.95
Other Current Assets2.30
Prepaid Expense And Other Assets Current0.92
Total Current Assets21.98
Equipment/Property/Plant Net0.37
Goodwill net25.74
Intangible Assets114.30
Other Assets, Noncurrent0.00
Reimbursement Right Asset Current2.30
Operating Lease Right Of Use Asset-
Total Assets162.40
Liabilities
Accounts Payable and Accrued Liabilities, Current LI3.49
Other Liabilities, Current0.00
Total Current Liabilities3.49
Total Long-term Debt0.00
Other liabilities, Noncurrent7.02
OperatingLeaseLiabilityNoncurrent-
Contract With Customer Liability Current-
Deferred Income Tax Liabilities Net0.23
Total Liabilities10.52
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock108.20
Retained Earnings / Accumulated Deficit-97.86
Defined Benefit Plan and Other0.43
Other Equity-141.98
Common Stockholder's Equity-131.21
Non-controlling interests & other141.54
Total Stockholder's Equity10.34
Liabilities & Stockholder's Equity162.40
4 historic quarters locked

Sign in to unlock the full Transcode Therapeutics Inc balance sheet history.

About Transcode Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-043810

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License